Cargando…

Drug interaction between hydroxychloroquine and metformin

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290148/ http://dx.doi.org/10.1007/s40278-020-79485-8

Ejemplares similares

Hydroxychloroquine concentrations persist after drug discontinuation
Publicado: (2022)

A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Hydroxychloroquine- and chloroquine-related cardiovascular events
Publicado: (2020)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Hydroxychloroquine in early pregnancy: risk of birth defects
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Hydroxychloroquine-related psychiatric disorders in COVID-19 patients
Publicado: (2020)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

Hydroxychloroquine in IgA nephropathy: a systematic review
por: Stefan, Gabriel, et al.
Publicado: (2021)

Drug-drug interactions in patients with COVID-19
Publicado: (2020)

Metformin-Associated Acute Kidney Injury and Lactic Acidosis
por: Arroyo, David, et al.
Publicado: (2011)

Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance
por: Du, Xuan, et al.
Publicado: (2018)

Hydroxychloroquine/chloroquine and the risk of acute kidney injury in COVID-19 patients: a systematic review and meta-analysis
por: Liao, Zheng-Ming, et al.
Publicado: (2022)

Interaction between favipiravir and hydroxychloroquine and their combined drug assessment: in silico investigations
por: Parlak, Cemal, et al.
Publicado: (2021)

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
por: Jensterle Sever, Mojca, et al.
Publicado: (2014)

Hydroxychloroquine and Potential Drug Interactions in Older Adults
por: Velasco-González, Verónica, et al.
Publicado: (2020)

Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
por: Weiss, Johanna, et al.
Publicado: (2020)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

The effect of metformin on apoptosis in a breast cancer presurgical trial
por: Cazzaniga, M, et al.
Publicado: (2013)

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
por: Saleh, Hend S., et al.
Publicado: (2016)

Effects of Metformin on the Cerebral Metabolic Changes in Type 2 Diabetic Patients
por: Huang, Yung-Cheng, et al.
Publicado: (2014)

Gallic acid improves the metformin effects on diabetic kidney disease in mice
por: Hong, Yan, et al.
Publicado: (2023)

Effects of hydroxychloroquine treatment on QT interval
por: Hooks, Matthew, et al.
Publicado: (2020)

Evaluation of Diabetic Patients with Breast Cancer Treated with Metformin during Adjuvant Radiotherapy
por: Ferro, Adam, et al.
Publicado: (2013)

Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Zhang, Rong, et al.
Publicado: (2017)

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
por: Garrett, C R, et al.
Publicado: (2012)

Assessment of Metformin as an Additional Treatment to Therapeutic Lifestyle Changes in Pediatric Patients with Metabolic Syndrome
por: Raub, Rebecca M., et al.
Publicado: (2012)

Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas
por: Braghiroli, Maria Ignez, et al.
Publicado: (2015)

Timing of Exercise Affects Glycemic Control in Type 2 Diabetes Patients Treated with Metformin
por: Huang, Tao, et al.
Publicado: (2018)

Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
por: Green, Charlotte J, et al.
Publicado: (2022)

METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours
por: Glasberg, João, et al.
Publicado: (2022)

Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers
por: Lesko, Lawrence J., et al.
Publicado: (2017)

Long-Term Effects of Metformin and Lifestyle Modification on Nonalcoholic Fatty Liver Disease Obese Adolescents
por: Tock, Lian, et al.
Publicado: (2010)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
por: Ma, J., et al.
Publicado: (2014)

Effects of a Comprehensive, Intensive Lifestyle Intervention Combined with Metformin Extended Release in Obese Adolescents
por: Clarson, Cheril L., et al.
Publicado: (2014)

Hydroxychloroquine‐induced erythema multiforme
por: Koumaki, Dimitra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eh4of1e6fr4j0uhaj4ihra3b8t